| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/16/2004 | US6706503 Generating preferential microorganisms; obtain microorganism containing mutant gene, express gene and evaluate microorganism mutation response |
| 03/16/2004 | US6706501 Isolated nucleic acid molecule comprising selected nucleic acid sequence, encoding protein having 10,12-linoleate isomerase activity |
| 03/16/2004 | US6706265 Immunosuppressing graft rejection |
| 03/16/2004 | CA2136961C Bnp antibody and immunoassay using it |
| 03/16/2004 | CA2122837C Method for refolding igf-1 to active conformation |
| 03/11/2004 | WO2004020638A1 Process for producing glucose dehydrogenases |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048778 Selective growth media |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048351 Alpha-amylase mutants |
| 03/11/2004 | US20040048348 Process for producing amide compound using microbial catalyst |
| 03/11/2004 | US20040048344 Method for producing d-pantothenic acid and/or the salt thereof as additive for other metallic surface (2) are provided.animal food |
| 03/11/2004 | US20040048337 Process for producing glutathione |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040047868 Administering probiotic, wherein the probiotic is probiotic bacteria selected from Lactobacillus species, with the proviso that the Lactobacillus species is not Lactobacillus GG for prophylaxis and therapy of endotoxemia |
| 03/11/2004 | US20040047850 Bifidobacteria and preparations containing them |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047842 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |
| 03/11/2004 | DE10239308A1 Fermentative production of sulfur-containing fine chemicals, useful e.g. as feed additive, by culturing bacteria containing heterologous sequence for methionine synthase |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396541A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 03/10/2004 | EP1396533A1 Process for preparing an oil containing one or more long chain polyunsaturated fatty acids from biomass, food, nutritional composition, cosmetic or pharmaceutical composition containing said oil |
| 03/10/2004 | EP1395676A1 Viral drug susceptibility testing |
| 03/10/2004 | EP1395665A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 03/10/2004 | EP1198554B1 Detection of micro-organisms |
| 03/10/2004 | EP1111991A4 Method of performing transgenesis |
| 03/10/2004 | EP0792351B1 Method for producing a human neural cell line |
| 03/10/2004 | EP0771360B1 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 03/10/2004 | EP0762894B1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/10/2004 | EP0651653B1 p53 VACCINE |
| 03/10/2004 | CN1481504A Screening assay for antagonists of human leukocyte receptors |
| 03/10/2004 | CN1480528A Bifidobacterium and products contg same |
| 03/10/2004 | CN1141387C Novel PPGPP synthetase and expression systems for improved production of protein of interest |
| 03/10/2004 | CN1141317C Cyelosporin derivatives with anti-HIV effect |
| 03/09/2004 | US6703484 Generating prferential polypeptides; obtain cells, transform with expression vector, culture cell, recover preferential polypeptides |
| 03/09/2004 | US6703233 Used for stabilizing expression plasmids for use in a genetic vaccine; removes sole dependence on catalytic balanced lethal maintenance system, incorporates a plasmid partition system preventing random segregation of plasmids |
| 03/09/2004 | CA2263992C Sequential hybridization of fungal cell dna and method for the detection of fungal cells in clinical material |
| 03/04/2004 | WO2004018651A1 Novel microorgnaism sensitive to lysozyme |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002002811B1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043451 Production process of surfactin |
| 03/04/2004 | US20040043444 Fermentation process using specific oxygen uptake rates as a process control |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043109 Non-maltogenic exoamylases and their use in retarding retrogradation of starch |
| 03/04/2004 | US20040043035 Recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 03/04/2004 | US20040043012 Lactic acid bacteria cultures that inhibit food-borne pathogens |
| 03/04/2004 | DE10239082A1 Fermentative production of sulfur-containing fine chemicals, useful e.g. as feed additive, by culturing bacteria containing heterologous sequence for O-acetylhomoserine sulfhydrolase |
| 03/03/2004 | EP1394542A1 Method of screening prion disease infection factor |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1393067A1 Encapsulated cell indicator system |
| 03/03/2004 | EP1392816A1 Production of bioavailable folic acid |
| 03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP0871459B1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 03/03/2004 | EP0797671B1 A process of producing extracellular proteins in bacteria |
| 03/03/2004 | EP0647268B1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 03/03/2004 | CN1478895A Purified plyporus laccase and nucleic acid for coating the laccase |
| 03/03/2004 | CN1140629C Genes of purine biosynthesis from ashbya gossypli and use thereof in microbial riboflavin synothesis |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/02/2004 | US6699981 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 03/02/2004 | US6699700 A mutant of the alcaligenes enzyme; production from an escherichia coli host cell; insusceptible to bilirubin when measuring creatinine due to its optimum weakly acidic ph range |
| 03/02/2004 | US6699695 For example, converting 2-hydroxy-4-methylthiobutyronitrile into the corresponding amide, which is a precursor to the feed supplement 2-hydroxy-4-methylthiobutyric acid |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699479 Recombinant newcastle disease virus as an embryo vaccine |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016798A1 Process for producing theanine |
| 02/26/2004 | WO2004016729A2 SYSTEMS AND METHODS FOR CONTROL OF pH AND OTHER REACTOR ENVIRONMENTAL CONDITIONS |
| 02/26/2004 | WO2004016727A1 Determination and/or control of reactor environmental conditions |
| 02/26/2004 | WO2004001054A3 Flocculation with divalent salt |
| 02/26/2004 | WO2003066815A3 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002083890A3 Use of clya hemolysin for excretion of fusion proteins |
| 02/26/2004 | WO2002042336A3 Fgf-affinity chromatography |
| 02/26/2004 | US20040040062 Method for producing human lactoferrin in plant cell culture |
| 02/26/2004 | US20040038430 Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 02/26/2004 | US20040038410 Composition for the preservation of viruses |
| 02/26/2004 | US20040038380 Bacterial strain of escherichia coli BKIIM B-3996 as the producer of L-threonine |
| 02/26/2004 | US20040038379 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038352 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 02/26/2004 | US20040038351 By reacting glyceraldehyde 3-phosphate and acetaldehyde in the presence of either a microorganism itself which contains 2-deoxyribose-5- phosphate aldolase but substantially no phosphatase or the enzyme derived from the microorganism |
| 02/26/2004 | US20040038263 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/26/2004 | US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds |
| 02/26/2004 | CA2495617A1 Determination and/or control of reactor environmental conditions |
| 02/25/2004 | EP1391517A1 Process for producing glutathione |
| 02/25/2004 | EP1390541A2 Method for detecting gram-positive bacteria |
| 02/25/2004 | EP1390532A2 Amplification process |
| 02/25/2004 | EP1390520A1 Production method and preparation method of glucans |